Venom Antiserum is a medication made from antibodies which is used to treat certain venomous bites and stings. They are recommended only if there is significant toxicity or a high risk of toxicity. The specific Venom Antiserum needed depends on the species involved. It is given by injection.
LPI (LP Information)' newest research report, the “Venom Antiserum Industry Forecast” looks at past sales and reviews total world Venom Antiserum sales in 2022, providing a comprehensive analysis by region and market sector of projected Venom Antiserum sales for 2023 through 2029. With Venom Antiserum sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Venom Antiserum industry.
This Insight Report provides a comprehensive analysis of the global Venom Antiserum landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Venom Antiserum portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Venom Antiserum market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Venom Antiserum and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Venom Antiserum.
The global Venom Antiserum market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Venom Antiserum is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Venom Antiserum is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Venom Antiserum is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Venom Antiserum players cover CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts and Bharat Serums and Vaccines, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Venom Antiserum market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Polyvalent
Monovalent
Segmentation by application
Hospitals and Clinics
Non-profit Institutions
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Key Questions Addressed in this Report
What is the 10-year outlook for the global Venom Antiserum market?
What factors are driving Venom Antiserum market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Venom Antiserum market opportunities vary by end market size?
How does Venom Antiserum break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Venom Antiserum Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Venom Antiserum by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Venom Antiserum by Country/Region, 2018, 2022 & 2029 2.2 Venom Antiserum Segment by Type 2.2.1 Polyvalent 2.2.2 Monovalent 2.3 Venom Antiserum Sales by Type 2.3.1 Global Venom Antiserum Sales Market Share by Type (2018-2023) 2.3.2 Global Venom Antiserum Revenue and Market Share by Type (2018-2023) 2.3.3 Global Venom Antiserum Sale Price by Type (2018-2023) 2.4 Venom Antiserum Segment by Application 2.4.1 Hospitals and Clinics 2.4.2 Non-profit Institutions 2.5 Venom Antiserum Sales by Application 2.5.1 Global Venom Antiserum Sale Market Share by Application (2018-2023) 2.5.2 Global Venom Antiserum Revenue and Market Share by Application (2018-2023) 2.5.3 Global Venom Antiserum Sale Price by Application (2018-2023) 3 Global Venom Antiserum by Company 3.1 Global Venom Antiserum Breakdown Data by Company 3.1.1 Global Venom Antiserum Annual Sales by Company (2018-2023) 3.1.2 Global Venom Antiserum Sales Market Share by Company (2018-2023) 3.2 Global Venom Antiserum Annual Revenue by Company (2018-2023) 3.2.1 Global Venom Antiserum Revenue by Company (2018-2023) 3.2.2 Global Venom Antiserum Revenue Market Share by Company (2018-2023) 3.3 Global Venom Antiserum Sale Price by Company 3.4 Key Manufacturers Venom Antiserum Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Venom Antiserum Product Location Distribution 3.4.2 Players Venom Antiserum Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Venom Antiserum by Geographic Region 4.1 World Historic Venom Antiserum Market Size by Geographic Region (2018-2023) 4.1.1 Global Venom Antiserum Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Venom Antiserum Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Venom Antiserum Market Size by Country/Region (2018-2023) 4.2.1 Global Venom Antiserum Annual Sales by Country/Region (2018-2023) 4.2.2 Global Venom Antiserum Annual Revenue by Country/Region (2018-2023) 4.3 Americas Venom Antiserum Sales Growth 4.4 APAC Venom Antiserum Sales Growth 4.5 Europe Venom Antiserum Sales Growth 4.6 Middle East & Africa Venom Antiserum Sales Growth 5 Americas 5.1 Americas Venom Antiserum Sales by Country 5.1.1 Americas Venom Antiserum Sales by Country (2018-2023) 5.1.2 Americas Venom Antiserum Revenue by Country (2018-2023) 5.2 Americas Venom Antiserum Sales by Type 5.3 Americas Venom Antiserum Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Venom Antiserum Sales by Region 6.1.1 APAC Venom Antiserum Sales by Region (2018-2023) 6.1.2 APAC Venom Antiserum Revenue by Region (2018-2023) 6.2 APAC Venom Antiserum Sales by Type 6.3 APAC Venom Antiserum Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Venom Antiserum by Country 7.1.1 Europe Venom Antiserum Sales by Country (2018-2023) 7.1.2 Europe Venom Antiserum Revenue by Country (2018-2023) 7.2 Europe Venom Antiserum Sales by Type 7.3 Europe Venom Antiserum Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Venom Antiserum by Country 8.1.1 Middle East & Africa Venom Antiserum Sales by Country (2018-2023) 8.1.2 Middle East & Africa Venom Antiserum Revenue by Country (2018-2023) 8.2 Middle East & Africa Venom Antiserum Sales by Type 8.3 Middle East & Africa Venom Antiserum Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Venom Antiserum 10.3 Manufacturing Process Analysis of Venom Antiserum 10.4 Industry Chain Structure of Venom Antiserum 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Venom Antiserum Distributors 11.3 Venom Antiserum Customer 12 World Forecast Review for Venom Antiserum by Geographic Region 12.1 Global Venom Antiserum Market Size Forecast by Region 12.1.1 Global Venom Antiserum Forecast by Region (2024-2029) 12.1.2 Global Venom Antiserum Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Venom Antiserum Forecast by Type 12.7 Global Venom Antiserum Forecast by Application 13 Key Players Analysis 13.1 CSL 13.1.1 CSL Company Information 13.1.2 CSL Venom Antiserum Product Portfolios and Specifications 13.1.3 CSL Venom Antiserum Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 CSL Main Business Overview 13.1.5 CSL Latest Developments 13.2 Merck 13.2.1 Merck Company Information 13.2.2 Merck Venom Antiserum Product Portfolios and Specifications 13.2.3 Merck Venom Antiserum Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Merck Main Business Overview 13.2.5 Merck Latest Developments 13.3 BTG 13.3.1 BTG Company Information 13.3.2 BTG Venom Antiserum Product Portfolios and Specifications 13.3.3 BTG Venom Antiserum Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 BTG Main Business Overview 13.3.5 BTG Latest Developments 13.4 Pfizer 13.4.1 Pfizer Company Information 13.4.2 Pfizer Venom Antiserum Product Portfolios and Specifications 13.4.3 Pfizer Venom Antiserum Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Pfizer Main Business Overview 13.4.5 Pfizer Latest Developments 13.5 Haffkine Bio-Pharmaceutical 13.5.1 Haffkine Bio-Pharmaceutical Company Information 13.5.2 Haffkine Bio-Pharmaceutical Venom Antiserum Product Portfolios and Specifications 13.5.3 Haffkine Bio-Pharmaceutical Venom Antiserum Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Haffkine Bio-Pharmaceutical Main Business Overview 13.5.5 Haffkine Bio-Pharmaceutical Latest Developments 13.6 Rare Disease Therapeutics 13.6.1 Rare Disease Therapeutics Company Information 13.6.2 Rare Disease Therapeutics Venom Antiserum Product Portfolios and Specifications 13.6.3 Rare Disease Therapeutics Venom Antiserum Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Rare Disease Therapeutics Main Business Overview 13.6.5 Rare Disease Therapeutics Latest Developments 13.7 Flynn Pharma 13.7.1 Flynn Pharma Company Information 13.7.2 Flynn Pharma Venom Antiserum Product Portfolios and Specifications 13.7.3 Flynn Pharma Venom Antiserum Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Flynn Pharma Main Business Overview 13.7.5 Flynn Pharma Latest Developments 13.8 Vins Bioproducts 13.8.1 Vins Bioproducts Company Information 13.8.2 Vins Bioproducts Venom Antiserum Product Portfolios and Specifications 13.8.3 Vins Bioproducts Venom Antiserum Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Vins Bioproducts Main Business Overview 13.8.5 Vins Bioproducts Latest Developments 13.9 Bharat Serums and Vaccines 13.9.1 Bharat Serums and Vaccines Company Information 13.9.2 Bharat Serums and Vaccines Venom Antiserum Product Portfolios and Specifications 13.9.3 Bharat Serums and Vaccines Venom Antiserum Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Bharat Serums and Vaccines Main Business Overview 13.9.5 Bharat Serums and Vaccines Latest Developments 13.10 Serum Biotech 13.10.1 Serum Biotech Company Information 13.10.2 Serum Biotech Venom Antiserum Product Portfolios and Specifications 13.10.3 Serum Biotech Venom Antiserum Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Serum Biotech Main Business Overview 13.10.5 Serum Biotech Latest Developments 13.11 MicroPharm 13.11.1 MicroPharm Company Information 13.11.2 MicroPharm Venom Antiserum Product Portfolios and Specifications 13.11.3 MicroPharm Venom Antiserum Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 MicroPharm Main Business Overview 13.11.5 MicroPharm Latest Developments 14 Research Findings and Conclusion